Other Publications
Su YJ, Kramer AM, Hamilton MP, Agarwal N, Srinagesh HK, Baird JH, Sahaf B, Kuo A, Ehlinger ZJ, Desai MH, Rietberg SP, Tunuguntla R, Patel S, Chinnasamy H, Gkitsas-Long N, Klysz DD, Brown AK, Bharadwaj S, Dahiya S, Smith M, Muffly L, Mackall CL, Good Z, Feldman SA, Miklos DB, Frank MJ. (2025). Effects of an initial anti-CD19 CAR T-cell therapy on subsequent anti-CD22 CAR T-cell manufacturing and clinical outcomes in patients with relapsed/refractory LBCL. Cancer Discovery, 15(4): 733-747. PMID: 39775812.
Hamilton MP*, Sugio T*, Noordenbos T*, Shi S, Bulterys PL, Long Liu C, Olsen MN, Good Z, Dahiya S, Frank MJ, Sahaf B, Mackall CL, Gratzinger D, Diehn M, Alizadeh AA§, Miklos DB§. (2024). Risk of second malignancies & T-cell lymphoma after chimeric antigen receptor T-cell therapy. New England Journal of Medicine, 390(22): 2047-2060. PMID: 38865660.
Yamada-Hunter SA*, Theruvath J*, Radosevich MT, McIntosh BJ, Freitas KA, Leruste A, Dhingra S, Martinez-Velez N, Mount CW, Sotillo E, Xu P, Delaidelli A, Desai MH, Sahaf B, Good Z, Labanieh L, Heitzeneder S, Banuelos A, Khan O, Marjon KD, Huang J, Wasserman SL, Spiegel JY, Sorensen PH, Monje M, Majzner RG, Weissman IL, Cochran JR, Mackall CL. (2024). Selective phagocytosis of tumor cells while sparing T cells using engineered CD47 enhances antitumor immunity. Nature, 630(8016):457-465. PMID: 38750365.
Hamilton MP, Craig E, Gentille Sanchez C, Mina A, Tamaresis J, Kirmani N, Ehlinger Z, Syal S, Good Z, Sworder B, Schroers-Martin J, Lu Y, Muffly L, Negrin R, Arai S, Lowsky R, Meyer E, Rezvani A, Shizuru J, Weng W, Shiraz P, Sidana S, Bharadwaj S, Smith M, Dahiya S, Sahaf B, Kurtz D, Mackall C, Tibshirani R, Alizadeh A, Frank M, Miklos D. (2024). CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity. Blood Advances, 8(12):3314-3326. PMID: 38498731.
Zhang W, Li I, Reticker-Flynn NE, Good Z, Chang S, Samusik N, Saumyaa S, Li Y, Zhou X, Liang R, Kong CS, Le QT, Gentles AJ, Sunwoo JB, Nolan GP, Engleman EG, Plevritis SK. (2022). Identification of cell types in multiplexed in situ images by combining protein expression and spatial location using CELESTA reveals spatial biology. Nature Methods, 19(6): 759-769. PMID: 35654951.
Simonetta F, Alam IS, Lohmeyer JK, Sahaf B, Good Z, Chen W, Xiao Z, Hirai T, Scheller L, Engels P, Vermesh O, Robinson E, Haywood T, Sathirachindra A, Baker J, Malipotlalla MB, Schultz LM, Spiegel JY, Lee JT, Miklos DB, Mackall CL, Gambhir SS, Negrin RS. (2021). Molecular imaging of chimeric antigen receptor T cells by ICOS-immunoPET. Clinical Cancer Research, 27(4): 1058-68. PMID: 33087332
Samusik N, Good Z, Spitzer MH, Davis KL, Nolan GP. (2016). Automated mapping of phenotype space with single-cell data. Nature Methods, 13(6): 493-6. PMID: 27183440.
Dauphinee SM, Voelcker V, Tebaykina Z, Wong F, Karsan A. (2011). Heterotrimeric Gi/Go proteins modulate endothelial TLR signaling independent of the MyD88-dependent pathway. American Journal of Physiology - Heart and Circulatory Physiology, 301(6): H2246-53. PMID: 21949112.
Alvarez-Breckenridge C, Anderson, KG, Correia AL, Demehri S, Dinh HQ, Dixon KO, Dunn GP, Evgin L, Goc J, Good Z, Hacohen N§, Han P, Hanč P, Hickey JW, Kersten K, Liu BC, Buqué A, Mao Y, Milner JJ, Pritykin Y, Pucci F, Scharping NE, Sudmeier L, Wang Y, Wieland A, Williams MW. (2023). Lessons for the next generation of scientists from the 2nd annual Arthur and Sandra Irving Cancer Immunology Symposium. Cancer Immunology Research, 11(12): 1571-1577. PMID: 37906619.
Bucktrout SL, Banovich NE, Butterfield LH, Cimen-Bozkus C, Giles JR, Good Z, Goodman D, Jonsson V, Laraeu C, Marson A, Maurer DM, Munson PV, Stubbington M, Taylor S, Cutchin A. (2022). Advancing T cell-based cancer therapy with single cell technologies. Nature Medicine, 28(9): 1761-1764. PMID: 36127419.
Majzner RG*, Ramakrishna S*, Yeom KW, Patel S, Chinnasamy H, Schultz LM, Richards RM, Barsan V, Mancusi R, Geraghty AC, Good Z, Mochizuki A, Gillespie SM, Martin A, Toland S, Mahdi J, Reschke A, Chau I, Nie E, Chau AJ, Rotiroti MC, Mount CW, Baggott C, Mavroukakis S, Egeler E, Moon J, Erickson C, Green S, Kunicki M, Fujimoto M, Ehlinger Z, Reynolds W, Kurra S, Warren KE, Prabhu S, Vogel H, Rasmussen L, Cornell TT, Partap S, Fisher PG, Campen CJ, Filbin M, Grant G, Sahaf B, Davis KL, Feldman SA, Mackall CL§, Monje M§. (2022). GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature, 603(7903): 934-941. PMID: 35130560.
Weber EW, Lynn RC, Parker KR, Lattin J, Anbunathan H, Sotillo E, Good Z, Malipatlolla M, Xu P, Vandris P, Majzner RG, Chen L-C, Wandless TJ, Chang HY, Satpathy AT, Mackall CL. (2021). Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. Science, 2;372(6537): eaba1786. PMID: 33795428.
Lynn RC, Weber EW, Sotillo E, Gennert D, Xu P, Good Z, Anbunathan H, Lattin J, Jones R, Tieu V, Granja J, DeBourcy C, Xu P, Majzner R, Satpathy AT, Quake SR, Chang H, Mackall CL. (2019). c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature, 576(7786): 293-300. PMID: 31802004.
Enquist IB, Good Z, Jubb AM, Fuh G, Wang X, Junttila MR, Jackson EL, Leong KG. (2014). Lymph node-independent liver metastasis in a model of metastatic colorectal cancer. Nature Communications, 5: 3530. PMID: 24667486.
Fahy GM, Brooke RT, Watson JP, Good Z, Vasanawala SS, Maecker H, Leipold M, Lin DTS, Kobor MS, Horvath S. (2019). Reversal of epigenetic aging and immunosenescent trends in humans. Aging Cell, 18(6): e13028. PMID: 31496122.
Franci C, Zhou J, Jiang Z, Modrasan Z, Good Z, Jackson EL, Kouros-Mehr H. (2013). Biomarkers of residual disease, disseminated tumor cells, and metastases in the MTV-PyMT breast cancer model. PLoS ONE, 8(3): e58183. PMID: 23520493.
Strauss DM, Lute S, Tebaykina Z, Frey DD, Ho C, Blank GS, Brorson K, Chen Q, Yang B. (2009). Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics. Biotechnology & Bioengineering, 104(2): 371-80. PMID: 19575414.